Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists

Abstract

Background and study aims Retrospectively, minimally 5% of patients with esophageal squamous cell carcinoma (ESCC) and 11 % with head and neck squamous cell carcinoma (HNSCC) in Western countries developed a second primary tumor (SPT). SPT screening in ESCC and HNSCC patients is not implemented routinely in daily practice in many Western countries. This study aimed to assess medical specialist knowledge and opinions regarding screening for head and neck SPTs (HNSPTs) in ESCC patients and vice versa in the Netherlands.

Methods A nationwide survey among gastroenterologists and head and neck (HN) surgeons was conducted between December 2020 and March 2021. The survey consisted of 27 questions and focused on knowledge of medical specialists of the prevalence and opinions toward implementing screening for HNSPTs in ESCC patients and vice versa.

Results One hundred twenty-eight gastroenterologists (20.5 %) and 31 HN surgeons (50.0 %) completed the survey. The expected median prevalence of HNSPTs in ESCC was 7.0 % (interquartile range [IQR]: 5.0–15.0) among gastroenterologists and 5.0 % (IQR:3.0–8.0) among HN surgeons. For ESPTs in HNSCC, the expected median prevalence was 9.5 % (IQR: 5.0–12.0) among gastroenterologists and 4.0 % (IQR: 2.0–5.0) among HN surgeons. Screening for HNSPTs and ESPTs was considered promising by 35.2 % and 39.6 %, respectively, which increased to 54.7 % of the specialists after providing incidence data on SPTs. Of the HN surgeons, 41.3 % felt they were as capable as gastroenterologists of performing esophageal screening.

Conclusions This Dutch nationwide survey revealed a lack of knowledge and different perspectives among specialists about screening to detect SPTs in ESCC and HNSCC patients. Adequate education seems essential to increase awareness among specialists and improve SPT detection, independent of the need for implementation of screening for SPTs in ESCC and HNSCC patients.

Publikationsverlauf

Eingereicht: 04. Februar 2022

Angenommen nach Revision: 30. Mai 2022

Artikel online veröffentlicht:
14. September 2022

• References

• 1 Bugter O, van de Ven SEM, Hardillo JA. et al. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck 2019; 41: 1122-1130
• 2 Bugter O, van Iwaarden DLP, Dronkers EAC. et al. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable. Head Nec 2019; 41: 1648-1655
• 3 van de Ven S, Bugter O, Hardillo JA. et al. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis. United European Gastroenterol J 2019; 7: 1304-1311
• 4 van de Ven SE, Falger JM, Verhoeven RH. et al. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: A nationwide study in a Western population. United European Gastroenterol J 2020;
• 5 Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968
• 6 Bugter O, Spaander MCW, Bruno MJ. et al. Optical detection of field cancerization in the buccal mucosa of patients with esophageal cancer. Clin Transl Gastroenterol 2018; 9: 152
• 7 Watanabe A, Hosokawa M, Taniguchi M. et al. Head and neck cancer associated with esophageal cancer. Auris Nasus Larynx 2007; 34: 207-211
• 8 Onochi K, Shiga H, Takahashi S. et al. Risk factors linking esophageal squamous cell carcinoma with head and neck cancer or gastric cancer. J Clin Gastroenterol 2019; 53: e164-e170
• 9 Lo OS, Law S, Wei WI. et al. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?. Ann Surg Oncol 2008; 15: 1750-1756
• 10 Gong EJ, Kim DH, Ahn JY. et al. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study. Dis Esophagus 2016; 29: 752-759
• 11 Wang CH, Lee YC, Wang CP. et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety. Dig Endosc 2014; 26: 24-31
• 12 Arnold M, Ferlay J, van Berge Henegouwen MI. et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 2020; 69: 1564-1571
• 13 Ferlay J, Colombet M, Soerjomataram I. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941-1953
• 14 Hashimoto CL, Iriya K, Baba ER. et al. Lugolʼs dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 2005; 100: 275-282
• 15 Dubuc J, Legoux J, Winnock M. et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006; 38: 690-695
• 16 Boller D, Spieler P, Schoenegg R. et al. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Surg Endosc 2009; 23: 2748-2754
• 17 van de Ven SEM, de Graaf W, Bugter O. et al. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer. Dis Esophagus 2021; 34: doab037
• 18 Nobre Moura R, Kuboki Y, Baba ER. et al. Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma. Endosc Int Open 2022; 10: E200-E208
• 19 Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines 5th edition 2016. Available at: https://www.entuk.org/resources/131/5th_edition_head_and_neck_cancer_multidisciplinary_management_guidelines/
• 20 Guideline esophageal cancer (in Dutch: Richtlijn Oesofaguscarcinoom): Dutch society of gastroenterologists; Version 3.1. Available at: https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Richtlijn_Oesofaguscarcinoom.pdf
• 21 Wang WL, Wang CP, Wang HP. et al. The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer. Oral Oncol 2013; 49: 808-813
• 22 Chung CS, Lo WC, Lee YC. et al. Image-enhanced endoscopy for detection of second primary neoplasm in patients with esophageal and head and neck cancer: A systematic review and meta-analysis. Head Neck 2016; 38: E2343-E2349
• 23 Kumai Y, Shono T, Waki K. et al. Detection of hypopharyngeal cancer (Tis, T1 and T2) by ENT physicians vs gastrointestinal endoscopists. Auris Nasus Larynx 2020; 47: 135-140
• 24 Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. . Cancer 1961; 14: 221-230
• 25 Leemans CR, Smeele LE, Langendijk JA. et al. Guideline head and neck cancer (in Dutch: richtlijn Hoofd-halstumoren) 2012. Available at: https://richtlijnendatabase.nl/richtlijn/hoofd-halstumoren/hoofd-halstumoren_-_korte_beschrijving.html
• 26 de Mones E, Bertolus C, Salaun PY. et al. Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 2013; 130: 107-112
• 27 Su H-A, Hsiao S-W, Hsu Y-C. et al. Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis. BMC Cancer 2020; 20: 1-9
• 28 Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngology Head Neck Surgery 2019; 48: 1-5
• 29 Van Kooten H, de Jonge V, Schreuders E. et al. Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada. Canadian J Gastroenterol 2012; 26: 79-84